Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12968/hmed.2021.0112 http://scihub22266oqcxt.onion/10.12968/hmed.2021.0112 33792391!ä!33792391 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Hosp+Med+(Lond) 2021 ; 82 (3): 1-9 Nephropedia Template TP {{tp|p=33792391|t=2021. Treatment of COVID-19: a review of current and prospective pharmacotherapies |pdf=|usr=}}{{33792391}} gab.com Text Treatment of COVID-19: a review of current and prospective pharmacotherapies JO: Br J Hosp Med (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=33792391 #FOAvip The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread and have grave health and socioeconomic consequences worldwide. Researchers have raced to understand the pathophysiological mechanisms underpinning the disease caused by SARS-CoV-2 so that effective therapeutic targets can be discovered. This review summarises the key pharmacotherapies that are being investigated for treatment of COVID-19, including antiviral, immunomodulator and anticoagulation strategies. Twit Text FOAVip Treatment of COVID-19: a review of current and prospective pharmacotherapies ????Br J Hosp Med (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=33792391 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33792391 #FOAvip English Wikipedia <ref>{{Cite pmid|33792391}}</ref> Treatment of COVID-19: a review of current and prospective pharmacotherapies #MMPMID33792391 Quek E; Tahir H; Kumar P; Hastings R; Jha R Br J Hosp Med (Lond) 2021[Mar]; 82 (3): 1-9 PMID33792391show ga The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread and have grave health and socioeconomic consequences worldwide. Researchers have raced to understand the pathophysiological mechanisms underpinning the disease caused by SARS-CoV-2 so that effective therapeutic targets can be discovered. This review summarises the key pharmacotherapies that are being investigated for treatment of COVID-19, including antiviral, immunomodulator and anticoagulation strategies. |*COVID-19 Drug Treatment[MESH] |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Anticoagulants/*therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Azetidines/therapeutic use[MESH] |COVID-19 Serotherapy[MESH] |COVID-19/therapy[MESH] |Colchicine/therapeutic use[MESH] |Dexamethasone/therapeutic use[MESH] |Glucocorticoids/*therapeutic use[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Immunologic Factors/*therapeutic use[MESH] |Ivermectin/therapeutic use[MESH] |Janus Kinase Inhibitors/therapeutic use[MESH] |Platelet Aggregation Inhibitors/*therapeutic use[MESH] |Purines/therapeutic use[MESH] |Pyrazoles/therapeutic use[MESH] |SARS-CoV-2[MESH]Treatment of COVID-19: a review of current and prospective pharmacothe(epmc).pdf DeepDyve Pubget Overpricing